期刊文献+

高效液相-质谱法测定血浆雷米普利与雷米普利拉浓度 被引量:1

下载PDF
导出
摘要 目的建立高效液相-质谱(HPLC-MS/MS)法测定血浆雷米普利和雷米普利拉浓度。方法含雷米普利和雷米普利拉的血浆样品,以依那普利为内标,用乙腈沉淀蛋白,流动相为0.1%甲酸溶液-乙腈(64:46),流速:0.2 mL.min-1,柱温45℃,采用HPLC-MS/MS法同时测定雷米普利和雷米普利拉浓度。结果雷米普利和雷米普利拉在2.5~200.0 ng.mL-1浓度范围内线性关系良好,日内和日间RSD<8%(n=6)。结论该方法具有良好的准确性、精密性,较高的灵敏度,操作简便、快速,适用于雷米普利和雷米普利拉血浆浓度监测。
出处 《医药导报》 CAS 2007年第9期992-993,共2页 Herald of Medicine
  • 相关文献

参考文献2

二级参考文献10

  • 1Erman A,Wnkler J,Chen-Gal B,et aI.Inhibition of angiotensinconverting enzyme by edpril in serum and tissue of man[].Journal of Hypertension l.199
  • 2Zannad F.Trandolapril: How does it differ from other angiotensinconverting enzyme inhibitors[].Drugs.1993
  • 3Rosenthal,J,Buehler,G,Koenig,W,Rangoonwala,B.Effect of angiotensin-converting enzyme inhibition on human tissue renin[].Journal of Cardiovascular Pharmacology.1991
  • 4Ball SG,Cowan JC,Winter C.Effect of ramipril on mortality andmorbidity of suvivors of acute myocardial infarction with clinicalevidence of heart failure[].The Lancet.1993
  • 5Hoechest-Roussel Pharmaceuticals Inc.Drug reference/prescribing information[]..1992
  • 6Ruddy MC,Mroczek WJ.Comparison of ramipril and enalapril inpatients with essential hypertension[].Pharmacotherapy.1993
  • 7Zabludowski J,Rosenfeld J,Akbary ma,et al.A multi-centre comparativestudy between randpril and enalapril in pahent with hold to moderateessential hypertension[].Current Medical Research and Opinion.1988
  • 8McCarron D,ramipril MSG.24 - Hour blood pressure profiles inhypertensive patients administered ramipril or placebo once daily:magnitude and duration of antihypertensive effects[].Clinical Cardiology.1991
  • 9Spieker C,Zidek W Vetter H,et al.Ambulatory 24 -h blood pressuremonitoring in essential hypertensive treated with the angiotensin-converting enzyme inhibitor randpril[].Journal of International Medical Research.1991
  • 10Todd PA.Benfield R Rdripril:a review of its phannacological propertiesand therapeutic efficacy in cardiovascular disorders[].Drugs.1990

共引文献5

同被引文献12

  • 1黄圣凯,韩可勤.生物等效性评价的几种统计方法[J].中国临床药理学杂志,1993,9(1):43-46. 被引量:125
  • 2中国药典2005年版.二部[S].2005:137.
  • 3Campbell DJ,Kladis A,Duncan AM.Nephrectomy,converting enzymeinhibition,and angiotensin peptides[J].Hypertension,1993,22(4),513-522.
  • 4Gotti R,Andrisano V,Cavrini V,et al.Analysis of ACE-inhibitors by CE using alkylsulfonic additives[J].J Pharm Biomed Anal,2000,22(3):423-431.
  • 5Persson BA,Fakt C,Ervik M,et al.Interference from a glucuronide metabolite in the determination of ramipril and ramiprilat in human plasma and urine by gas chromatography-mass spectrometry[J].J Pharm Biomed Anal,2006,40(3):794-798.
  • 6Baraka MM,El-Sadek M,Moussa EM,et al.Spectrophotometric and atomic absorption determination of ramipril,enalapril maleate and fosinopril through ternary complex formation with molybdenum(Ⅴ)-thiocyanate(Mo(Ⅴ)-SCN)[J].Chem Pharm Bull(Tokyo),2008,56(11):1521-1527.
  • 7Hogan BL,Williams M,Idiculla A,et al.Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules[J].J Pharm Biomed Anal,2000,23(4):637-651.
  • 8Bonazzi D,Gotti R,Andrisano V,et al.Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography(HPLC)[J].J Pharm Biomed Anal,1997,16(3):431-438.
  • 9美国药典24版,(1090)In Vivo Bioequivalence Guidance:2058.
  • 10张象麟.MCDEX药物临床信息参考[M].成都:四川科学技术出版社,2007.464.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部